Aspire Growth Partners »

Regeneron Pharmaceuticals shares owned by Aspire Growth Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Aspire Growth Partners from 13F filings

Historical chart of Aspire Growth Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Aspire Growth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Aspire Growth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $483k 626 771.40
2025-09-30 $351k 625 562.15
2025-06-30 $328k 624 524.92

More positions owned by Aspire Growth Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Capital Group Core Equity Et Shs Creation Uni (CGUS)
Capital Group Dividend Value Shs Creation Uni (CGDV)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Alphabet Cap Stk Cl C (GOOG)
Wal-Mart Stores (WMT)
Amazon (AMZN)
International Business Machines (IBM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Aspire Growth Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals